Abstract
Autophagy is a relevant cellular defense mechanism that directly eliminates intracellular pathogens and has a crucial role for innate and adaptive immune responses. Some viruses have developed tools to counteract this cellular response. A179L, the viral Bcl2 homolog of African swine fever virus, interacts with proapoptotic Bcl2 family proteins to inhibit apoptosis. Here we report that this gene manipulates autophagy by interacting with Beclin 1 through its BH3 homology domain. At subcellular level, A179L colocalized with Beclin 1 at mitochondria and the endoplasmic reticulum. Virus infection inhibited autophagosome formation in cells; however, when autophagy was induced prior to or at the time of infection the number of infected cells was severely decreased.
Keywords: African swine fever virus, ASFV, autophagy, Beclin 1, BH3-only proteins, ER stress, viral Bcl2, viral Bcl2 homolog, autophagosomes, stress, starvation, homeostasis, hemorrhagic disease, pathogenesis, lymphoid hyperplasia.
Current Molecular Medicine
Title:A179L, a New Viral Bcl2 Homolog Targeting Beclin 1 Autophagy Related Protein
Volume: 13 Issue: 2
Author(s): B. Hernaez, M. Cabezas, R. Munoz-Moreno, I. Galindo, M. A. Cuesta-Geijo and C. Alonso
Affiliation:
Keywords: African swine fever virus, ASFV, autophagy, Beclin 1, BH3-only proteins, ER stress, viral Bcl2, viral Bcl2 homolog, autophagosomes, stress, starvation, homeostasis, hemorrhagic disease, pathogenesis, lymphoid hyperplasia.
Abstract: Autophagy is a relevant cellular defense mechanism that directly eliminates intracellular pathogens and has a crucial role for innate and adaptive immune responses. Some viruses have developed tools to counteract this cellular response. A179L, the viral Bcl2 homolog of African swine fever virus, interacts with proapoptotic Bcl2 family proteins to inhibit apoptosis. Here we report that this gene manipulates autophagy by interacting with Beclin 1 through its BH3 homology domain. At subcellular level, A179L colocalized with Beclin 1 at mitochondria and the endoplasmic reticulum. Virus infection inhibited autophagosome formation in cells; however, when autophagy was induced prior to or at the time of infection the number of infected cells was severely decreased.
Export Options
About this article
Cite this article as:
Hernaez B., Cabezas M., Munoz-Moreno R., Galindo I., Cuesta-Geijo A. M. and Alonso C., A179L, a New Viral Bcl2 Homolog Targeting Beclin 1 Autophagy Related Protein, Current Molecular Medicine 2013; 13 (2) . https://dx.doi.org/10.2174/15665240113130200007
DOI https://dx.doi.org/10.2174/15665240113130200007 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nanocarriers for Tracking and Treating Diseases
Current Medicinal Chemistry Recent Progress in Chemically Modified siRNAs
Mini-Reviews in Medicinal Chemistry The Potential of T Cell Immunoglobulin and Mucin-Domain Containing-3 (Tim-3) in Designing Novel Immunotherapy for Bladder Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets Asymmetric Syntheses Based on Organocatalysis
Mini-Reviews in Organic Chemistry Targeted Liposomal Drug Delivery in Cancer
Current Pharmaceutical Design Using Insights into Pim1 Structure to Design New Anticancer Drugs
Current Pharmaceutical Design Gene Therapy to Overcome Drug Resistance in Cancer: Targeting Key Regulators of the Apoptotic Pathway
Current Gene Therapy Insight into the Binding Mode between HIV-1 Integrase and Pyrimidone Analogue Inhibitors with MD Simulation and 3D-QSAR
Medicinal Chemistry Plant Cells as Pharmaceutical Factories
Current Pharmaceutical Design SANTAVAC ™: A Novel Universal Antigen Composition for Developing Cancer Vaccines
Recent Patents on Biotechnology Bugs as Drugs: Understanding the Linkage between Gut Microbiota and Cancer Treatment
Current Drug Targets Advances in the Management of Brain Tumors in Infants
Current Cancer Therapy Reviews When BMP Signalling Goes Wrong: The Intracellular and Molecular Mechanisms of BMP Signalling in Cancer
Current Signal Transduction Therapy Functional Role of miR-34 Family in Human Cancer
Current Drug Targets Viral Vector-Mediated Gene Therapy for Hemophilia
Current Gene Therapy Anti-tumoral Properties of Endogenous Angiogenesis Inhibitors: A Case for Continued TIMP-2 Preclinical Development
Current Angiogenesis (Discontinued) Meet Our Editorial Board Member
Letters in Drug Design & Discovery Does Ligand Symmetry Play a Role in the Stabilization of DNA G-Quadruplex Host-Guest Complexes?
Current Medicinal Chemistry Regulating miRNA by Natural Agents as a New Strategy for Cancer Treatment
Current Drug Targets Recent Advances in the Discovery of Novel HSP90 Inhibitors: An Update from 2014
Current Drug Targets